Loading
Latest filing published 19 Nov 2008 for SCOLR Pharma, Inc., €202.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Daniel O. Wilds appears in our data through filings on SCOLR Pharma, Inc. shares, published by SEC (Form 4). We count 42 filings; the first trade dates from 16 May 2006 and the latest from 19 November 2008.
Purchases make up the whole of the open-market record (41 purchases, €125k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant. In 2008 alone, the filings show 12 purchases and no sales.
The median purchase comes to €2,135.
The record was last updated on 19 November 2008 with an open-market purchase (€157) in SCOLR Pharma, Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 34 declarations